m+Medelevator.RU
← Поиск публикаций
Pain management · 2026

Effect of transcutaneous electrical nerve stimulation associated to exercise for pain in Parkinson's disease: a randomized crossover clinical trial.

СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Garcez P A, DeJesus B M, Oliveira L R, Lima L V, DeSantana J M

Аннотация

INTRODUCTION: Parkinson's disease (PD) causes debilitating motor and non-motor symptoms, including chronic pain. While TENS and exercise are potential treatments, their combined effects require investigation.

OBJECTIVE: To assess the effect of TENS added to an exercise program on pain intensity (primary outcome), fatigue, temporal summation, pain catastrophizing, skin sensitivity, and depression in PD.

METHODS: This randomized, double-blind, crossover trial included 13 patients (Hoehn & Yahr II-III). Participants received active or placebo TENS (1:1 ratio) followed by the reverse order after a 7-day washout. Both phases included a 20-minute exercise program. Active TENS (100 Hz, 100 μs) was applied to thoracic and lumbar regions at motor threshold. Outcome assessors and participants were blinded to the intervention.

RESULTS: All 13 participants completed both phases (n = 26). Compared to placebo, the active TENS group showed significant improvements in primary outcome of pain intensity (p = 0.006). Significant improvements were also observed in temporal summation (p = 0.004) and cutaneous sensibility (thoracic right (p = 0.002), left (p = 0.041). No adverse events were reported during the interventions.

CONCLUSIONS: TENS combined with exercise is effective for reducing pain intensity, temporal summation, and fatigue, as well as improving cutaneous sensibility in patients with PD.

CLINICAL TRIAL REGISTRATION: ReBEC identifier is RBR-4bvwxq (UTN: U1111-1159-1101).

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты